A detailed history of Garde Capital, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Garde Capital, Inc. holds 2,084 shares of JNJ stock, worth $323,374. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,084
Previous 2,084 -0.0%
Holding current value
$323,374
Previous $329,000 7.29%
% of portfolio
0.02%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 21, 2024

BUY
$145.6 - $158.88 $43,680 - $47,664
300 Added 16.82%
2,084 $327,000
Q3 2023

Nov 17, 2023

SELL
$155.75 - $174.48 $509,769 - $571,073
-3,273 Reduced 64.72%
1,784 $278,000
Q2 2023

Aug 28, 2023

BUY
$154.35 - $166.11 $435,267 - $468,430
2,820 Added 126.06%
5,057 $837,000
Q1 2023

May 24, 2023

SELL
$151.05 - $180.26 $14,651 - $17,485
-97 Reduced 4.16%
2,237 $347,000
Q4 2022

Feb 24, 2023

BUY
$160.2 - $179.79 $6,087 - $6,832
38 Added 1.66%
2,334 $412,000
Q2 2022

Aug 23, 2022

BUY
$168.19 - $186.01 $3,363 - $3,720
20 Added 0.88%
2,296 $408,000
Q1 2022

May 27, 2022

SELL
$158.14 - $179.59 $157,507 - $178,871
-996 Reduced 30.44%
2,276 $403,000
Q4 2021

Feb 25, 2022

SELL
$155.93 - $173.01 $8,732 - $9,688
-56 Reduced 1.68%
3,272 $560,000
Q3 2021

Nov 17, 2021

SELL
$161.5 - $179.47 $31,815 - $35,355
-197 Reduced 5.59%
3,328 $537,000
Q2 2021

Aug 19, 2021

SELL
$159.48 - $171.07 $22,167 - $23,778
-139 Reduced 3.79%
3,525 $581,000
Q1 2021

May 24, 2021

SELL
$153.07 - $170.48 $16,225 - $18,070
-106 Reduced 2.81%
3,664 $602,000
Q4 2020

Feb 26, 2021

SELL
$137.11 - $157.38 $18,372 - $21,088
-134 Reduced 3.43%
3,770 $593,000
Q3 2020

Nov 17, 2020

BUY
$140.38 - $153.83 $42,394 - $46,456
302 Added 8.38%
3,904 $581,000
Q2 2020

Sep 02, 2020

BUY
$128.81 - $155.51 $25,504 - $30,790
198 Added 5.82%
3,602 $507,000
Q1 2020

May 08, 2020

SELL
$111.14 - $153.99 $11,669 - $16,168
-105 Reduced 2.99%
3,404 $446,000
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $15,682 - $18,012
123 Added 3.63%
3,509 $512,000
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $36,434 - $40,794
287 Added 9.26%
3,386 $438,000
Q2 2019

Aug 20, 2019

BUY
$131.15 - $144.24 $30,295 - $33,319
231 Added 8.05%
3,099 $432,000
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $599,432 - $666,518
-4,768 Reduced 62.44%
2,868 $401,000
Q4 2018

Feb 20, 2019

BUY
$122.84 - $147.84 $859 - $1,034
7 Added 0.09%
7,636 $985,000
Q3 2018

Nov 19, 2018

BUY
$121.58 - $142.88 $102,613 - $120,590
844 Added 12.44%
7,629 $1.1 Million
Q2 2018

Aug 20, 2018

SELL
$119.4 - $131.76 $8,119 - $8,959
-68 Reduced 0.99%
6,785 $823,000
Q1 2018

May 16, 2018

BUY
$125.1 - $148.14 $24,394 - $28,887
195 Added 2.93%
6,853 $878,000
Q4 2017

Feb 23, 2018

SELL
$131.22 - $143.62 $59,836 - $65,490
-456 Reduced 6.41%
6,658 $930,000
Q3 2017

Nov 17, 2017

BUY
$129.47 - $135.38 $921,049 - $963,093
7,114
7,114 $925,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Garde Capital, Inc. Portfolio

Follow Garde Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Garde Capital, Inc. with notifications on news.